You have free access to this content

Hepatology

Cover image for Vol. 52 Issue 5

November 2010

Volume 52, Issue 5

Pages 1527–1867

  1. Comments from the Editors

    1. Top of page
    2. Comments from the Editors
    3. Editorial
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
      Working with a gold-plated standard (page 1527)

      Terry Therneau

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.24021

  2. Editorial

    1. Top of page
    2. Comments from the Editors
    3. Editorial
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
  3. Viral Hepatitis

    1. Top of page
    2. Comments from the Editors
    3. Editorial
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
      Association of anti-E1E2 antibodies with spontaneous recovery or sustained viral response to therapy in patients infected with hepatitis C virus (pages 1531–1542)

      Ndiémé Ndongo, Pascale Berthillon, Pierre Pradat, Claude Vieux, Isabelle Bordes, Françoise Berby, Marianne Maynard, Fabien Zoulim, Christian Trépo and Marie-Anne Petit

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23862

    2. You have free access to this content
      Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1 (pages 1543–1552)

      Salvatore Petta, Marco Amato, Daniela Cabibi, Calogero Cammà, Vito Di Marco, Carla Giordano, Aldo Galluzzo and Antonio Craxì

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23859

    3. You have free access to this content
      Anti–tumor necrosis factor α treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C (pages 1553–1563)

      Erwin Daniel Brenndörfer, Malin Weiland, Lars Frelin, Emma Derk, Gustaf Ahlén, Jian Jiao, Johannes Georg Bode and Matti Sällberg

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23870

    4. You have free access to this content
      Frequent multiple hepatitis C virus infections among injection drug users in a prison setting (pages 1564–1572)

      Son T. Pham, Rowena A. Bull, James M. Bennett, William D. Rawlinson, Gregory J. Dore, Andrew R. Lloyd and Peter A. White

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23885

    5. You have free access to this content
      Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6 (pages 1573–1580)

      Khoa D. Lam, Huy N. Trinh, Son T. Do, Thuan T. Nguyen, Ruel T. Garcia, Tuan Nguyen, Quang Q. Phan, Huy A. Nguyen, Khanh K. Nguyen, Long H. Nguyen and Mindie H. Nguyen

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23889

    6. You have free access to this content
      Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro (pages 1581–1589)

      Lucy Golden-Mason, Andrea L. Cox, Jessica A. Randall, Linling Cheng and Hugo R. Rosen

      Article first published online: 1 SEP 2010 | DOI: 10.1002/hep.23896

      Corrected by:

      Correction: Erratum

      Vol. 53, Issue 1, 377, Article first published online: 12 JAN 2011

    7. You have free access to this content
      Antiviral activity of narlaprevir combined with ritonavir and pegylated interferon in chronic hepatitis C patients (pages 1590–1599)

      Joep de Bruijne, Jilling F. Bergmann, Henk W. Reesink, Christine J. Weegink, Richard Molenkamp, Janke Schinkel, Xiao Tong, Jing Li, Michelle A. Treitel, Eric A. Hughes, Jan Jaap van Lier, Andre A. van Vliet, Harry L. A. Janssen and Robert J. de Knegt

      Article first published online: 11 OCT 2010 | DOI: 10.1002/hep.23899

    8. You have free access to this content
      Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection (pages 1600–1610)

      Mira El Chaar, Daniel Candotti, R. Anthony Crowther and Jean Pierre Allain

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23886

    9. You have free access to this content
      Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen–positive patients (pages 1611–1620)

      Karsten Wursthorn, Mechthild Jung, Antonio Riva, Zachary D. Goodman, Patricia Lopez, Weibin Bao, Michael P. Manns, Heiner Wedemeyer and Nikolai V. Naoumov

      Article first published online: 7 OCT 2010 | DOI: 10.1002/hep.23905

  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Comments from the Editors
    3. Editorial
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
      Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis (pages 1621–1631)

      Nuria Martínez-López, Marta Varela-Rey, David Fernández-Ramos, Ashwin Woodhoo, Mercedes Vázquez-Chantada, Nieves Embade, Luis Espinosa-Hevia, Francisco Javier Bustamante, Luis A. Parada, Manuel S. Rodriguez, Shelly C. Lu, José M. Mato and Maria L. Martínez-Chantar

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23860

    2. You have free access to this content
      Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity (pages 1632–1642)

      Nirupa Sachithanandan, Barbara C. Fam, Stacey Fynch, Nicolas Dzamko, Matthew J. Watt, Sam Wormald, Jane Honeyman, Sandra Galic, Joseph Proietto, Sofianos Andrikopoulos, Andrea L. Hevener, Thomas W.H. Kay and Gregory R. Steinberg

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23861

    3. You have free access to this content
      Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease (pages 1643–1651)

      Lucia Pacifico, Caterina Anania, Francesco Martino, Vito Cantisani, Roberto Pascone, Andrea Marcantonio and Claudio Chiesa

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23890

    4. You have free access to this content
      Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins (pages 1652–1661)

      Paola Vitaglione, Filomena Morisco, Giovanna Mazzone, Daniela Caterina Amoruso, Maria Teresa Ribecco, Antonietta Romano, Vincenzo Fogliano, Nicola Caporaso and Giuseppe D'Argenio

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23902

      Corrected by:

      Correction: Correction

      Vol. 53, Issue 4, 1416, Article first published online: 7 APR 2011

    5. You have free access to this content
      Mutation analysis and characterization of alternative splice variants of the Wilson disease gene ATP7B (pages 1662–1670)

      Lei Wan, Chang-Hai Tsai, Chin-Moo Hsu, Chin-Chang Huang, Chih-Chao Yang, Chiu-Chu Liao, Chin-Ching Wu, Yu-An Hsu, Cheng-Chun Lee, Su-Ching Liu, Wei-De Lin and Fuu-Jen Tsai

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23865

    6. You have full text access to this OnlineOpen article
      A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis (pages 1671–1779)

      Pradyumna Phatak, Pierre Brissot, Mark Wurster, Paul C Adams, Herbert L. Bonkovsky, John Gross, Peter Malfertheiner, Gordon D. McLaren, Claus Niederau, Alberto Piperno, Lawrie W. Powell, Mark W. Russo, Ulrich Stoelzel, Wolfgang Stremmel, Louis Griffel, Nicola Lynch, Yiyun Zhang and Antonello Pietrangelo

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23879

  5. Hepatobiliary Malignancies

    1. Top of page
    2. Comments from the Editors
    3. Editorial
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
      The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3–dependent Wnt activation (pages 1680–1689)

      Jin-Ping Lai, Abdul M. Oseini, Catherine D. Moser, Chunrong Yu, Sherine F. Elsawa, Chunling Hu, Ikuo Nakamura, Tao Han, Ileana Aderca, Hajime Isomoto, Megan M. Garrity-Park, Abdirashid M. Shire, Jia Li, Schuyler O. Sanderson, Alex A. Adjei, Martin E. Fernandez-Zapico and Lewis R. Roberts

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23848

    2. You have free access to this content
      Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma (pages 1690–1701)

      Chian-Feng Chen, En-Chi Hsu, Kuen-Tyng Lin, Pang-Hsien Tu, Hung-Wei Chang, Chin-Hui Lin, Yann-Jang Chen, De-Leung Gu, Chi-Hung Lin, Jer-Yuarn Wu, Yuan-Tsong Chen, Ming-Ta Hsu and Yuh-Shan Jou

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23847

    3. You have free access to this content
      A novel GSK-3 beta–C/EBP alpha–miR-122–insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma (pages 1702–1712)

      Chunxian Zeng, Ruizhi Wang, Daochuan Li, Xue-Jia Lin, Qing-Kun Wei, Yunfei Yuan, Qing Wang, Wen Chen and Shi-Mei Zhuang

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23875

    4. You have free access to this content
      Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis (pages 1713–1722)

      Dipali Sharma, Jason Wang, Ping P. Fu, Shvetank Sharma, Arumugam Nagalingam, Jamie Mells, Jeffrey Handy, Andrew J. Page, Cynthia Cohen, Frank A. Anania and Neeraj K. Saxena

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23892

    5. You have free access to this content
      Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: The importance of tumor cell differentiation (pages 1723–1730)

      Massimo Iavarone, Angelo Sangiovanni, Laura Virginia Forzenigo, Sara Massironi, Mirella Fraquelli, Alessio Aghemo, Guido Ronchi, Piero Biondetti, Massimo Roncalli and Massimo Colombo

      Article first published online: 14 SEP 2010 | DOI: 10.1002/hep.23903

    6. You have free access to this content
      MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B (pages 1731–1740)

      Linhui Liang, Chun-Ming Wong, Qiao Ying, Dorothy Ngo-Yin Fan, Shenglin Huang, Jie Ding, Jian Yao, Mingxia Yan, Jinjun Li, Ming Yao, Irene Oi-Lin Ng and Xianghuo He

      Article first published online: 8 SEP 2010 | DOI: 10.1002/hep.23904

    7. You have free access to this content
      Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival (pages 1741–1749)

      Philip Hilgard, Monia Hamami, Amr El Fouly, André Scherag, Stefan Müller, Judith Ertle, Till Heusner, Vito R. Cicinnati, Andreas Paul, Andreas Bockisch, Guido Gerken and Gerald Antoch

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23944

    8. You have free access to this content
  6. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Comments from the Editors
    3. Editorial
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
      Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid–induced cholestasis in rat liver (pages 1758–1768)

      Gerald U. Denk, Silvia Maitz, Ralf Wimmer, Christian Rust, Pietro Invernizzi, Sacha Ferdinandusse, Wim Kulik, Andrea Fuchsbichler, Peter Fickert, Michael Trauner, Alan F. Hofmann and Ulrich Beuers

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23911

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Comments from the Editors
    3. Editorial
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
      The fractalkine receptor CX3CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes (pages 1769–1782)

      Karlin Raja Karlmark, Henning W. Zimmermann, Christoph Roderburg, Nikolaus Gassler, Hermann E. Wasmuth, Tom Luedde, Christian Trautwein and Frank Tacke

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23894

    2. You have free access to this content
      Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension (pages 1783–1790)

      Elsa Solà, Sabela Lens, Mónica Guevara, Marta Martín-Llahí, Claudia Fagundes, Gustavo Pereira, Marco Pavesi, Javier Fernández, Juan González-Abraldes, Angels Escorsell, Antoni Mas, Jaume Bosch, Vicente Arroyo and Pere Ginès

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23893

  8. Liver Injury/Regeneration

    1. Top of page
    2. Comments from the Editors
    3. Editorial
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
      Polymerase γ Gene POLG determines the risk of sodium valproate-induced liver toxicity (pages 1791–1796)

      Joanna D. Stewart, Rita Horvath, Enrico Baruffini, Iliana Ferrero, Stefanie Bulst, Paul B. Watkins, Robert J. Fontana, Christopher P. Day and Patrick F. Chinnery

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23891

  9. Liver Biology/Pathobiology

    1. Top of page
    2. Comments from the Editors
    3. Editorial
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
      Liver X receptor α and farnesoid X receptor are major transcriptional regulators of OATP1B1 (pages 1797–1807)

      Henriette E. Meyer zu Schwabedissen, Kerstin Böttcher, Amarjit Chaudhry, Heyo K. Kroemer, Erin G. Schuetz and Richard B. Kim

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23876

    2. You have free access to this content
    3. You have free access to this content
      Adenosine triphosphate release and purinergic (P2) receptor–mediated secretion in small and large mouse cholangiocytes (pages 1819–1828)

      Kangmee Woo, Meghana Sathe, Charles Kresge, Victoria Esser, Yoshiyuki Ueno, Julie Venter, Shannon S. Glaser, Gianfranco Alpini and Andrew P. Feranchak

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23883

  10. Reviews

    1. Top of page
    2. Comments from the Editors
    3. Editorial
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
    2. You have free access to this content
  11. Hepatology Elsewhere

    1. Top of page
    2. Comments from the Editors
    3. Editorial
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Nonalcoholic fatty liver disease: is it all in the genes? (pages 1851–1854)

      Dawn McDowell Torres and Stephen A. Harrison

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.24020

  12. Image of the Month

    1. Top of page
    2. Comments from the Editors
    3. Editorial
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
      Massive hepatomegaly and involvement by Janus kinase 2–positive myeloproliferative neoplasm (pages 1855–1856)

      Jochen K. M. Lennerz, David J. Kuter, Robert Hasserjian and John Iafrate

      Article first published online: 1 OCT 2010 | DOI: 10.1002/hep.23913

  13. Correspondence

    1. Top of page
    2. Comments from the Editors
    3. Editorial
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Image of the Month
    14. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Reply: (pages 1857–1858)

      Michael P. Manns, Albert J. Czaja, James D. Gorham, Edward L. Krawitt, Giorgina Mieli-Vergani, Diego Vergani and John M. Vierling

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23949

    3. You have free access to this content
      On the mercapturic acid pathway of nitric oxide: is S-nitrosoglutathione present in the bile? (pages 1858–1859)

      Dimitrios Tsikas, Alexander A. Zoerner, Frank-Mathias Gutzki and Ranieri Rossi

      Article first published online: 1 OCT 2010 | DOI: 10.1002/hep.23926

    4. You have free access to this content
      Reply: (pages 1859–1860)

      Carlos M. Rodriguez-Ortigosa, Fernando Corrales, Juan F. Medina and Jesús Prieto

      Article first published online: 11 OCT 2010 | DOI: 10.1002/hep.23955

    5. You have free access to this content
      Observed and calculated interleukin-28B genotype frequencies in hepatitis C virus infection (pages 1860–1861)

      Magnus Lindh, Martin Lagging, Gunnar Norkrans and Kristoffer Hellstrand

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23963

    6. You have free access to this content
      Reply: (pages 1861–1862)

      Marco Antonio Montes-Cano, José Raúl García-Lozano, Cristina Abad-Molina, Manuel Romero-Gómez, Natalia Barroso, José Aguilar-Reina, Antonio Núñez-Roldán and María Francisca González-Escribano

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23988

    7. You have free access to this content
    8. You have free access to this content
      Reply: (page 1863)

      Peter Jepsen, Peter Ott, Per Kragh Andersen, Henrik Toft Sørensen and Hendrik Vilstrup

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.24019

    9. You have free access to this content
    10. You have free access to this content
    11. You have free access to this content
      Complications of alcoholic liver cirrhosis: Active assessment by endoscopy and sonography (pages 1864–1865)

      Yi-Wen Huang, Jui-Ting Hu and Sien-Sing Yang

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23799

    12. You have free access to this content
      Hypouricemic therapy: A novel potential therapeutic option for nonalcoholic fatty liver disease (pages 1865–1866)

      Cheng-Fu Xu, Chao-Hui Yu, Lei Xu, Xiao-Ying Sa and You-Ming Li

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23798

    13. You have free access to this content
    14. You have free access to this content
      Pegylated interferon and ribavirin in real life: Efficacy versus effectiveness (page 1867)

      Ângelo Zambam de Mattos, Paulo Roberto Lerias de Almeida, Cristiane Valle Tovo and Angelo Alves de Mattos

      Article first published online: 29 OCT 2010 | DOI: 10.1002/hep.23824

SEARCH

SEARCH BY CITATION